MORGAN STANLEY PLC/CALL/CVS HEALTH/80/0.1/20.12.24 Stock

Warrant

DE000MB33SY1

Market Closed - Börse Stuttgart 02:30:01 2024-07-16 pm EDT
0.07 EUR +6.06% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/80/0.1/20.12.24
Current month+1.45%
1 month-18.60%
Date Price Change
24-07-16 0.07 +6.06%
24-07-15 0.066 -10.81%
24-07-12 0.074 +12.12%
24-07-11 0.066 +6.45%
24-07-10 0.062 0.00%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 02:30 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33SY
ISINDE000MB33SY1
Date issued 2023-02-01
Strike 80 $
Maturity 2024-12-20 (157 Days)
Parity 10 : 1
Emission price 1.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.87
Lowest since issue 0.035
Spread 0.003
Spread %4.05%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
60.06 USD
Average target price
69.1 USD
Spread / Average Target
+15.04%
Consensus